Syndecan‐1 is Associated With Sinusoidal Obstruction Syndrome and Severe Acute Graft‐Versus‐Host Disease After Pediatric Hematopoietic Stem Cell Transplantation
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31943 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Denise Elbæk Horan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Hepatic Veno-Occlusive Disease, Syndecan-1. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Childhood Cancer Foundation, Dagmar Marshals Foundation, Tømrermester Jørgen Holm og Hustru Elisa, F. Hansen's Mindelegat.
Abstract (Originalsprache)
Endothelial damage may play a key role in several non‐infectious toxicities following hematopoietic stem cell transplantation (HSCT). We explored damage to the endothelial glycocalyx in 113 children undergoing HSCT by measuring syndecan‐1 plasma levels. Syndecan‐1 levels were elevated in patients with severe sinusoidal obstruction syndrome (SOS) and steroid‐refractory/dependent acute graft‐versus‐host disease, but remained low in milder cases. In patients with SOS, high syndecan‐1 levels were associated with prolonged diuretic treatment and thrombocytopenia. These findings provide new insights into the pathophysiology of endothelial‐related toxicities after HSCT and may lead to the development of more individualized and targeted therapeutic approaches.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- Institute for Inflammation Research, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- CAG Center for Endotheliomics, Department of Clinical Immunology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
- Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Denise Elbæk Horan, Sarah Weischendorff, Katrine Kielsen
Förderung
- Childhood Cancer Foundation
- Dagmar Marshals Foundation
- Tømrermester Jørgen Holm og Hustru Elisa, F. Hansen's Mindelegat
- BRIDGE - Translational Excellence Programme
- Danish Cancer Society
- Kræftens Bekæmpelse
Zitieren
APA
Horan, D. E., Weischendorff, S., Johansson, P. I., Ifversen, M., Nielsen, C. H., Müller, K., & Kielsen, K. (2025). Syndecan‐1 is Associated With Sinusoidal Obstruction Syndrome and Severe Acute Graft‐Versus‐Host Disease After Pediatric Hematopoietic Stem Cell Transplantation. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31943
Vancouver
Horan DE, Weischendorff S, Johansson PI, Ifversen M, Nielsen CH, Müller K, et al. Syndecan‐1 is Associated With Sinusoidal Obstruction Syndrome and Severe Acute Graft‐Versus‐Host Disease After Pediatric Hematopoietic Stem Cell Transplantation. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31943
BibTeX
@article{Horan2025,
author = {Horan, Denise Elbæk and Weischendorff, Sarah and Johansson, Pär I and Ifversen, Marianne and Nielsen, Claus H and Müller, Klaus and Kielsen, Katrine},
title = {Syndecan‐1 is Associated With Sinusoidal Obstruction Syndrome and Severe Acute Graft‐Versus‐Host Disease After Pediatric Hematopoietic Stem Cell Transplantation},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31943}
}
EUVIMED